History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online
Career Opportunities
Faculty Positions for physician-scientists in Translational Oncology

Over the past five years, cancer research has entered an exciting new era in which a number of highly effective, nontoxic targeted cancer therapies have been developed based on improved understanding of the molecular underpinnings of cancer. Examples of therapies include trastuzumab (Herceptin®) for breast cancer, imatinib (Gleevec®) for certain leukemias and sarcomas, erlotinib (Tarceva®) for lung cancer, and sunitinib (Sutent®) for kidney cancer, to name a few. The Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan-Kettering Cancer Center is a newly established program created to capitalize on the opportunities and address the challenges presented by this era. Successful translation of molecular insights into clinical trials requires that teams of physician-scientists with diverse clinical and scientific training work together. The mission of HOPP is to bring such individuals together under one roof and provide the resources and infrastructure required to achieve this goal.

Research Seminars
Research Seminars
Seminars are scheduled throughout the academic year

Over the past year we have been successful in recruiting several outstanding young physician-scientists to join us in HOPP, such that as of December 2007, we already had eight faculty members. Together, these individuals bring expertise in prostate, breast, lung, and thyroid cancers, as well as sarcoma, melanoma, glioblastoma, and leukemia, and have clinical training in oncology, hematology, radiation oncology, endocrinology, and pathology. We have also established infrastructure within HOPP to conduct molecular profiling studies of patient material on a routine basis. This information will guide the appropriate use of new molecularly targeted therapies in the clinical trials conducted at Memorial Sloan-Kettering.

Geoffrey Beene Cancer Research Center

The Human Oncology and Pathogenesis Program is a part of the Geoffrey Beene Cancer Research Center, established at Memorial Sloan-Kettering in 2006. For more information about the Geoffrey Beene Center, visit the Geoffrey Beene Cancer Research Center Web site.

Faculty


Bookmark and SharePrintEmail This Page